WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems getting existing vaccines to use in their research.
WASHINGTON — Senior Biden officials are in discussions about what to do with millions of original Covid-19 vaccines after the FDA’s authorization of new, updated shots this week bumped them to the sidelines.
Recent Comments